Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice

References

• Ferinject [summary of product characteristics]LondonVifor Pharma UK Ltd2011 [updated October 25]. Available at: http://www.medicines.org.uk/EMC/medicine/24167/SPC/Ferinject+(ferric+carboxymaltose)/Accessed November 9, 2011
   Google Scholar
• Monofer 100 mg/mL solution for injection/infusion [summary of product characteristics]LondonPharmacosmos UK Ltd2011 [updated March 21]. Available at: http://www.medicines.org.uk/EMC/medicine/23669/SPC/Monofer+100mg+ml+solution+for+injection+infusion/Accessed October 19, 2011
   Google Scholar
• GanzoniAMIntravenous iron-dextran: therapeutic and experimental possibilitiesSchweiz Med Wochenschr1970100301303 German5413918
   PubMedGoogle Scholar
• PeeblesGFenwickSIntravenous iron administration in a short-stay hospital settingNurs Stand200822354118727354
   PubMedGoogle Scholar
• GascheCBerstadABefritsRGuidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseasesInflamm Bowel Dis2007131545155317985376
   PubMed Web of Science ®Google Scholar
• BreymannCThe use of iron sucrose complex for anemia in pregnancy and the postpartum periodSemin Hematol200643Suppl 6S2831
   Web of Science ®Google Scholar
• BokemeyerCAoproMSCourdiAEORTC guidelines for the use of erythropoietic proteins in anemic patients with cancerEur J Cancer2004402201221615454245
   PubMed Web of Science ®Google Scholar
• AuerbachMBallardHTroutJRIntravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trialJ Clin Oncol2004221301130715051778
   PubMed Web of Science ®Google Scholar
• HaycoxAWhat is cost-minimisation analysis? What is …? SeriesLondonHayward Medical Communications2009 Available at: http://www.medicine.ox.ac.uk/bandolier/painres/download/whatis/What_is_cost-min.pdfAccessed October 3, 2011
   Google Scholar
• HigdonJIron [web page on the Internet]Corvallis, ORLinus Pauling Institute Available from: http://lpi.oregonstate.edu/infocenter/minerals/iron/Accessed October 3, 2011
   Google Scholar
• MoniemKABhandariSTolerability and efficacy of parenteral iron therapy in hemodialysis patients, a comparison of preparationsTransfus Altern Transfus Med2007913742
   Google Scholar
• MooreRAGaskellHRosePAllanJMeta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataBMC Blood Disord201111421942989
   PubMedGoogle Scholar
• HildebrandtPRBrunnNENielsenOWEffects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot studyTransfus Altern Transfus Med2010114131137
   Google Scholar
• BjornWBhandariSBaranyPIron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney diseaseJ Nephrol201124558959621240875
   PubMed Web of Science ®Google Scholar
• Department of HealthBetter Blood Transfusion: Safe and Appropriate Use of BloodHealth Service Circular HSC 2007/001LondonDepartment of Health2007 Available from: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_080803.pdfAccessed November 17, 2011
   Google Scholar
• Fisons ceases manufacture of ImferonThe Pharma Letter1993 Available at: http://www.thepharmaletter.com.file/92668/fisons-ceases-manufacture-of-imferon.htmlAccessed October 19, 2011
   Google Scholar
• CritchleyJDundarYAdverse events associated with intravenous iron infusion (low molecular weight iron dextran and iron sucrose): a systemic reviewTransfus Altern Transfus Med200791836
   Google Scholar
• Venofer (iron sucrose) [summary of product characteristics]LondonVifor Pharma UK Ltd2011 [updated March 30]. Available at: http://www.medicines.org.uk/EMC/medicine/24168/SPC/Venofer+(iron+sucrose)/Accessed November 9, 2011
   Google Scholar
• CosmoFer [summary of product characteristics]LondonPharmacosmos UK Ltd2011 [updated January 27]. Available at: http://www.medicines.org.uk/emc/medicine/14139/SPC/CosmoFer/Accessed October 19, 2011
   Google Scholar
• BhandariSA hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000Ther Clin Risk Manag2011710311321479141
   PubMed Web of Science ®Google Scholar
• RawnJThe silent risks of blood transfusionCurr Opin Anaesthesiol200821566466818784496
   PubMed Web of Science ®Google Scholar
• BhandariSBrownjohnATurneyJEffective utilization of erythropoietin with intravenous iron therapyJ Clin Pharm Ther199823173789756115
   PubMed Web of Science ®Google Scholar
• WeissGPathogenesis and treatment of anemia of chronic diseaseBlood Rev200216879612127952
   PubMed Web of Science ®Google Scholar
• AuerbachMCoyneDBallardHIntravenous iron: from anathema to standard of careAm J Hematol20088358058818273906
   PubMed Web of Science ®Google Scholar
• FishbaneSFreiGLMaesakaJReduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementationAm J Kidney Dis199526141467611266
   PubMed Web of Science ®Google Scholar
• MelamedNBen-HaroushAKaplanBYogevYIron supplementation in pregnancy – does the preparation matter?Arch Gynecol Obstet2007276660160417541618
   PubMedGoogle Scholar
• McClellandDBLHandbook of Transfusion Medicine4th edLondonStationary Office2007 Available from: http://www.transfusionguidelines.org.uk/docs/pdfs/htm_edition-4_all-pages.pdfAccessed February 9, 2011
   Google Scholar
• Van WyckDAndersonJJohnsonKLabile iron in parenteral iron formulations: a quantitative and comparative studyNephrol Dial Transplant20041956156514767009
   PubMed Web of Science ®Google Scholar
• GeisserPBaerMSchaubEStructure/histotoxicity relationship of parenteral iron formulationsArzneimittelforschung19924212143914521288508
   PubMed Web of Science ®Google Scholar
• ZagerRAJohnsonACHansonSYParenteral iron nephrotoxicity: potential mechanisms and consequencesKidney Int20046614415615200421
   PubMed Web of Science ®Google Scholar
• ZagerRAJohnsonACHansonSYWasseHParenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injuryAm J Kidney Dis20024019010312087566
   PubMed Web of Science ®Google Scholar
• AgarwalRVasavadaNSachsNGChaseSOxidative stress and renal injury with intravenous iron in patients with chronic kidney diseaseKidney Int2004652279228915149341
   PubMed Web of Science ®Google Scholar
• Doncaster and Bassetlaw Hospitals NHS Foundation TrustStaff crack down on wasted ambulance journeysDoncasterDoncaster and Bassetlaw Hospitals NHS Foundation Trust Available at: http://www.dbh.nhs.uk/Staffcrack_down_on_wasted_ambulance_journeys.aspAccessed March 2, 2010
   Google Scholar
• BhandariSNaudeerSImproving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choiceJ Eval Clin Pract200814996100118785894
   PubMed Web of Science ®Google Scholar
• CurtisLNurses [sections 12.1 and 12.2]Unit Costs of Health and Social Care, 2009CanterburyPersonal Social Services Research Unit University of Kent2009 Available at: http://www.pssru.ac.uk/pdf/uc/uc2009/uc2009_s12.pdfAccessed September 15, 2010
   Google Scholar
• CurtisLNurses [sections 14.1 and 14.2]Unit Costs of Health and Social Care, 2010 Nurses (sections 14.1 and 14.2)CanterburyPersonal Social Services Research Unit University of Kent2009 Available at: http://www.pssru.ac.uk/pdf/uc/uc2010/uc2010_s14.pdfAccessed June 27, 2011
   Google Scholar
• Venofer (Vifor)British National FormularyLondonThe Stationary Office2011 Available at: http://bnf.org/bnf/bnf/current/129558.htm#_129558Accessed October 19, 2011
   Google Scholar
• Cosmofer (Pharmacosmos UK)British National FormularyLondonThe Stationary Office2011 Available at: http://bnf.org/bnf/bnf/current/75068.htm#_75068Accessed October 19, 2011
   Google Scholar
• Ferinject (Vifor)British National FormularyLondonThe Stationary Office2011 Available at: http://bnf.org/bnf/bnf/current/201168.htm#_201168Accessed October 19, 2011
   Google Scholar
• Monofer (Pharmacosmos UK)British National FormularyLondonThe Stationary Office2011 Available at: http://bnf.org/bnf/bnf/current/213591.htm#_213591Accessed October 19, 2011
   Google Scholar
• Organ DonationNHSBT Annual Review 2009/10: Saving and Improving Lives [news release]BristolNHS Blood and Transplant2010 Available from: http://www.organdonation.nhs.uk/ukt/newsroom/news_releases/article.jsp?releaseId=249Accessed June 27, 2011
   Google Scholar